Shalby Ltd. SHALBY
NSE · India · Health Services
INR 133.55-5.10 (-3.68%)
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Consolidated revenue grows 11.6% YoY, but hospital EBITDA margins dip to 18.4% as Shalby International achieves first-ever EBITDA breakeven.
Shalby Ltd (BOM:540797) reports a remarkable turnaround with a 9.4% revenue increase and significant profit gains in Q4 2026.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.